A randomized, double-blind, placebo-controlled, parallel group study to explore the efficacy of PTR-36 in adult patients with bronchial asthma (Phase 2)

Trial Profile

A randomized, double-blind, placebo-controlled, parallel group study to explore the efficacy of PTR-36 in adult patients with bronchial asthma (Phase 2)

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Sep 2016

At a glance

  • Drugs ADC 3680 (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors Teijin Pharma
  • Most Recent Events

    • 25 Jul 2016 Status changed from recruiting to completed.
    • 08 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top